id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-E-1573-0007,FDA,FDA-2013-E-1573,Notice of Determination from U.S. Patent and Trademark Office to the FDA CDER,Other,Letter(s),2016-12-20T05:00:00Z,2016,12,2016-12-20T05:00:00Z,,2016-12-20T14:11:16Z,,0,0,0900006482429fce
FDA-2013-E-1573-0006,FDA,FDA-2013-E-1573,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2016-08-01T04:00:00Z,2016,8,2016-08-01T04:00:00Z,,2016-08-02T02:22:54Z,,0,0,090000648214b316
FDA-2013-E-1573-0005,FDA,FDA-2013-E-1573,"Determination of Regulatory Review Period for Purposes of Patent
Extension; VERAFLOX",Notice,Determinations,2015-12-10T05:00:00Z,2015,12,2015-12-10T05:00:00Z,2016-02-09T04:59:59Z,2015-12-10T16:53:17Z,2015-31099,0,0,0900006481d9ac55
FDA-2013-E-1573-0004,FDA,FDA-2013-E-1573,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2015-11-05T05:00:00Z,2015,11,2015-11-05T05:00:00Z,,2015-11-05T21:36:50Z,,0,0,0900006481d17c3e
FDA-2013-E-1573-0003,FDA,FDA-2013-E-1573,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2014-03-26T04:00:00Z,2014,3,2014-03-26T04:00:00Z,,2014-03-26T16:46:54Z,,0,0,0900006481683079
FDA-2013-E-1573-0002,FDA,FDA-2013-E-1573,Bayer Animal Health GMBH (Bayer HealthCare LLC) - Patent Term Application,Other,Application,2013-12-05T05:00:00Z,2013,12,2013-12-05T05:00:00Z,,2013-12-05T13:51:53Z,,0,0,09000064814aa149
FDA-2013-E-1573-0001,FDA,FDA-2013-E-1573,U.S. Patent and Trademark Office - Letter,Other,Letter(s),2013-12-05T05:00:00Z,2013,12,2013-12-05T05:00:00Z,,2013-12-05T13:51:53Z,,0,0,09000064814aa122